Leah Sibener, PhD

Co-Founder

Head of Therapeutic Discovery

Management Team

7+ years of experience & inventor of core 3T platform & technology
Previous experience – Discovery Immunology, Genentech
BA Biophysics, Johns Hopkins University
PhD immunology, Stanford University with Chris Garcia

Management Team

John Connolly, PhD

Hanspeter Gerber, PhD

Chief Scientific Officer

John Alves, CFA, MBA

Chief Financial Officer (Consulting)

Marvin Gee, PhD

Co-FounderHead of Target Discovery

Leah Sibener, PhD

Co-FounderHead of Therapeutic Discovery

Scientific Advisory Board

K. Christopher Garcia, PhD

Co-FounderChairman of the SABYounger Family Professor, Molecular & Cellular Physiology, Immunology, Structural Biology (Stanford), HHMI

Mark Davis, PhD

The Burt and Marion Avery Family Professor, Transplantation and Infection, Microbiology & Immunology (Stanford), HHMI

Stephen Schoenberger, PhD

Professor, Developmental Immunology (La Jolla Institute for Immunology)

Javier Chaparro-Riggers

Executive Director, Biotherapeutic Design & Discovery, Pfizer

Contributors

Lou Lange, MD, PhD

Deepa Pakianathan, PhD

Managing Member at Delphi Ventures